Dosimetric comparison of the carotid arteries in patients of T1 and T2 N0 M0 carcinoma glottis by three-dimensional conformal radiotherapy versus carotid sparing intensity-modulated radiotherapy technique
DOI:
https://doi.org/10.71152/ajms.v16i6.4546Keywords:
Glottic carcinoma; Radiation therapy; 3D conformal radiotherapy; Carotid-sparing intensity-modulated radiotherapy technique; DosimetricAbstract
Background: Radiotherapy (RT) is a cornerstone in the treatment of early-stage glottic carcinoma (T1 and T2 N0 M0). However, RT can lead to radiation-induced vasculopathy, which increases the risk of cerebrovascular complications. Carotidsparing intensity-modulated RT (Cs-IMRT) has been proposed to minimize radiation exposure to the carotid arteries while maintaining effective tumor control.
Aims and Objectives: This study aimed to compare the dosimetric impact of three-dimensional conformal RT (3DCRT) and Cs-IMRT on carotid artery exposure in patients with T1 and T2 N0 M0 carcinoma of the glottis.
Materials and Methods: This prospective comparative study included 30 patients equally divided into 3DCRT and Cs-IMRT treatment arms. Dosimetric parameters, including carotid artery dose exposure (V5Gy, V25Gy, and V50Gy), mean carotid dose, and local control rates, were analyzed.
Results: The mean carotid artery dose was lower in the Cs-IMRT group (43.2±9.7 Gy) than in the 3DCRT group (46.9±5.3 Gy, P=0.004). Cs-IMRT demonstrated a significant reduction in high-dose exposure, with V50Gy being 10.2±5.8% for Cs-IMRT versus 42.7±20.1% for 3DCRT (P<0.001). Similarly, Cs-IMRT achieved dose constraints more effectively, with 73.3% of patients meeting the V50Gy=0 criterion compared with none in the 3DCRT group. Although Cs-IMRT showed a slight improvement in local control rates, the difference was not significant (P=0.382).
Conclusion: Cs-IMRT showed significant dosimetric advantages over 3DCRT by reducing carotid artery radiation exposure, potentially lowering the risk of radiation-induced carotid artery vasculopathy. While both techniques achieved similar local control, the reduced vascular toxicity associated with Cs-IMRT supports its preferential use in early-stage glottic carcinoma.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Asian Journal of Medical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).